ROTHBLATT MARTINE A sold UTHR

December 18, 2025 · Form 4 insider transaction

ROTHBLATT MARTINE A sold 2,000 shares of United Therapeutics Corporation at $507.24 per share, a transaction worth $1.01M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
2,000
Price
$507.24
Total value
$1.01M
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 18, 2025
Filing dateDecember 19, 2025
Shares owned after2,130
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. The transactions reported on this Form 4 are the final trades under this plan.; This transaction was executed in multiple trades at prices ranging from $507.00 to $507.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR